The Prostate Cancer Foundation has awarded $225,000 across three years to UNC Lineberger’s Catherine C. Coombs, MD, to study whether genetic mutations that accumulate in the blood over time are linked to worse outcomes for prostate cancer. Coombs, an assistant professor in the UNC School of Medicine Division of Hematology/Oncology, received the Young Investigator Award … Continued
The Lung Cancer Initiative of North Carolina (LCI) has awarded The Vicky Amidon Innovation in Lung Cancer Research Award to Hongwei Du, PhD, a postdoctoral fellow at University of North Carolina School of Medicine and Lineberger Comprehensive Cancer Center. The award also was presented to Kenneth Adler, PhD, at the North Carolina State University College … Continued
UNC Lineberger researchers are betting that computer technology that has made self-driving cars and facial recognition possible could play a role in the next big cancer research discovery. “It’s the future of medicine,” said UNC Lineberger’s Charles M. Perou, PhD, the May Goldman Shaw Distinguished Professor of Molecular Oncology in the Department of Genetics and … Continued
The Web of Science Group’s 2019 Highly Cited Researchers list recognized 18 UNC Lineberger members for being among the world’s most influential researchers of the past decade. The listing is limited to researchers who have published multiple highly-cited papers that rank in the top 1 percent by citations for field and year. Approximately only 6,200 … Continued
The KRAS gene is commonly mutated in cancer. In the journal Cancer Discovery, researchers led by Channing Der, PhD, and Aaron Hobbs, PhD, reported details of the role of the KRAS G12R mutation in pancreatic cancer, and therapeutic strategies that might work for this mutation type. By studying unique differences in DNA mutations within the same gene, researchers are working to uncover the mutation-specific mechanisms that drive cancerous growth.
Chad Ellis, PhD, Ben Major, PhD, and Anne-Marie Meyer, PhD, traveled to the U.S. Capitol to meet with members of the North Carolina congressional delegation and explain the impact of National Institutes of Health and National Cancer Institute funding on the lives and well-being of people in North Carolina and the country.